Thrombocytopenia and clinical outcomes among patients with COVID-19 disease: A cohort study

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background and Aims: Thrombocytopenia is increasingly recognized among patients with critical illness and plays a role in several diseases affecting different organ systems. Therefore, we studied the prevalence of thrombocytopenia among hospitalized COVID-19 patients and its correlation with disease severity and clinical outcomes. Methods: This was an observational retrospective cohort study conducted on 256 hospitalized COVID-19 patients. Thrombocytopenia is defined as a platelet count below 150,000/μL. Disease severity was classified based on the five-point CXR scoring tool. Results: Thrombocytopenia was found in 66 (25.78%) patients. In outcomes, 41 (16%) patients were admitted to intensive care unit, 51 (19.9%) died, and 50 (19.5%) had acute kidney injury (AKI). Of the total patients with thrombocytopenia, 58 (87.9%) had early thrombocytopenia, while 8 (12.1%) had late thrombocytopenia. Notably, mean survival time was markedly decreased in late-onset thrombocytopenia cases (p < 0.0001). Patients with thrombocytopenia showed a significant increase in creatinine compared to those with normal platelet counts (p < 0.05). Moreover, thrombocytopenia was more prevalent in patients with chronic kidney disease compared to other comorbidities (p < 0.05). In addition, hemoglobin was significantly lower in the thrombocytopenia group (p < 0.05). Conclusion: Thrombocytopenia is a common finding among COVID-19 patients, with a predilection toward a specific group of patients, though the exact reasons are unclear. It predicts poor clinical outcomes and is closely linked to mortality, AKI, and the need for mechanical ventilation. These findings suggest that more research is required to study the mechanism of thrombocytopenia and the possibility of thrombotic microangiopathy in COVID-19 patients.

References Powered by Scopus

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

35159Citations
N/AReaders
Get full text

Kidney disease is associated with in-hospital death of patients with COVID-19

2066Citations
N/AReaders
Get full text

The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors

832Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Systemic Immune-Inflammation Index (SII) as a Predictor of Short-Term Mortality Risk in Sepsis-Associated Acute Kidney Injury: A Retrospective Cohort Study

2Citations
N/AReaders
Get full text

Linezolid-Associated Thrombocytopenia: Assessment of Risk Factors in Patients without Hemato-Oncologic Diseases

1Citations
N/AReaders
Get full text

Thrombocytopenia Secondary to COVID-19: Outcomes Analysis in Terms of Thrombotic Microangiopathy, Acute Kidney Injury, and Mortality

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Alkhalifa, H., Alsalman, Z., Alfaraj, A., Algaraash, M., & Alsalman, M. (2023). Thrombocytopenia and clinical outcomes among patients with COVID-19 disease: A cohort study. Health Science Reports, 6(2). https://doi.org/10.1002/hsr2.1111

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

33%

Engineering 2

33%

Medicine and Dentistry 1

17%

Nursing and Health Professions 1

17%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free